Avadel Pharmaceuticals plc

Historical 13F Holders

Symbol
AVDL
CUSIP
05337M104
All holders as of
Q1 2025
Type
Equity
Class
SPONSORED ADR
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q1 3 738 k $5.77 M
2024 Q4 3 737 k $7.75 M
2024 Q3 5 1.07 M $14.0 M
2024 Q2 10 7.03 M $98.8 M
2024 Q1 135 69.3 M $1.17 B
2023 Q4 129 57.6 M $814 M
2023 Q3 112 54.4 M $559 M
2023 Q2 113 52.0 M $858 M
2023 Q1 103 48.6 M $444 M
2022 Q4 100 33.5 M $240 M
2022 Q3 89 31.4 M $157 M
2022 Q2 92 33.7 M $82.4 M
2022 Q1 97 35.9 M $252 M
2021 Q4 104 35.2 M $284 M
2021 Q3 96 32.1 M $314 M
2021 Q2 92 32.6 M $219 M
2021 Q1 93 32.6 M $295 M
2020 Q4 96 32.2 M $215 M
2020 Q3 88 31.5 M $159 M
2020 Q2 89 36.3 M $294 M
2020 Q1 78 26.9 M $211 M
2019 Q4 51 18.4 M $139 M
2019 Q3 51 19.4 M $80.6 M
2019 Q2 51 19.6 M $56.6 M
2019 Q1 50 19.6 M $28.2 M
2018 Q4 62 19.8 M $51.1 M
2018 Q3 72 20.2 M $88.7 M
2018 Q2 83 21.2 M $130 M
2018 Q1 90 27.2 M $198 M
2017 Q4 86 26.4 M $217 M
2017 Q3 85 27.2 M $285 M
2017 Q2 79 27.8 M $306 M
2017 Q1 76 29.2 M $283 M
2016 Q4 6 4.30 M $44.7 M